PLEURAL MESOTHELIOMA
Clinical trials for PLEURAL MESOTHELIOMA explained in plain language.
Never miss a new study
Get alerted when new PLEURAL MESOTHELIOMA trials appear
Sign up with your email to follow new studies for PLEURAL MESOTHELIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immunotherapy boosts chemo in tough lung cancer trial
Disease control CompletedThis study tested adding the immunotherapy drug durvalumab to standard chemotherapy for people with advanced pleural mesothelioma that cannot be removed by surgery. The goal was to see if the combination helps patients live longer. About 214 adults took part, receiving either the…
Matched conditions: PLEURAL MESOTHELIOMA
Phase: PHASE3 • Sponsor: PrECOG, LLC. • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
300 patients help unlock secrets of lung fluid
Knowledge-focused CompletedThis study looked back at the medical records of 300 patients to find out what causes fluid to build up around the lungs (pleural effusion). The goal was to better understand the different reasons this happens, such as heart failure, infection, or cancer. By identifying patterns,…
Matched conditions: PLEURAL MESOTHELIOMA
Sponsor: Mansoura University Hospital • Aim: Knowledge-focused
Last updated May 12, 2026 13:42 UTC